SGLT2 Inhibitors May Cut Repeat Syncope in Type 2 Diabetes SGLT2 Inhibitors May Cut Repeat Syncope in Type 2 Diabetes

A prospective, multicenter study suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors improve cardiac autonomic dysfunction and reduce vaso-vagal syncope in patients with type 2 diabetes and prior syncope.First Look

Source: Medscape Cardiology Headlines - February 16, 2022 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news